» Articles » PMID: 36348227

Epidemiology of Herpes Zoster in Adults in Mexico: A Retrospective Database Analysis

Overview
Journal Infect Dis Ther
Date 2022 Nov 8
PMID 36348227
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The risk of herpes zoster (HZ) increases with age. In countries with an ageing population such as Mexico, a rise in the risk of HZ and complications is expected. The goal of this study was to provide an updated estimate of the potential burden of HZ and associated complications in Mexico.

Methods: A retrospective database study was performed using data from the national surveillance database of the Ministry of Health (Secretaría de Salubridad y Asistencia/Dirección General de Información en Salud). HZ cases and associated complications were identified via the International Classification of Diseases 10th Revision codes. Emergency room (ER) visits, hospitalizations, and deaths were extracted and analyzed by age group and year. The observation period was between 2011 and 2020 for ER visits and hospitalizations and between 2011 and 2019 for deaths. Cumulative incidence per 1000 people and case fatality rate were estimated.

Results: During the observation period, 53,030 ER visits, 4172 hospitalizations, and 263 deaths due to HZ were reported nationwide. The cumulative incidence of HZ based on ER visits was 1.04 per 1000 people aged ≥ 50 years but increased in older age groups (1.47 per 1000 people aged ≥ 65 years). The most common complications were neuralgia (10.9%), ocular disease (7.0%), meningoencephalitis (2.9%), and disseminated disease (3.1%). Patients ≥ 65 years accounted for 37% of hospitalizations and 81% of deaths.

Conclusion: In Mexico, HZ and its complications impose a considerable burden on the population and the healthcare system. Prospective surveillance studies are required to obtain an accurate picture of the current epidemiology of HZ in Mexico and to estimate the benefits of future vaccination strategies against HZ.

Citing Articles

Challenges and Opportunities for Adult Vaccine Coverage: Insights for Healthcare Professionals Focusing on Herpes Zoster in Mexico.

Cervantes-Apolinar M, Guzman-Holst A, Mascarenas De Los Santos A, Macias Hernandez A, Cabrera A, Lara-Solares A Vaccines (Basel). 2025; 12(12.

PMID: 39772101 PMC: 11680403. DOI: 10.3390/vaccines12121441.


Efficacy and safety of pulsed radiofrequency combined with pregabalin for herpetic neuralgia: A systematic review and meta-analysis.

Chen J, Lan L, Wang W, Xu X Medicine (Baltimore). 2023; 102(23):e33932.

PMID: 37335664 PMC: 10256363. DOI: 10.1097/MD.0000000000033932.

References
1.
Kawai K, Gebremeskel B, Acosta C . Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014; 4(6):e004833. PMC: 4067812. DOI: 10.1136/bmjopen-2014-004833. View

2.
Garcia-Gonzalez A, Rosas-Carrasco O . [Herpes zoster and post-herpetic neuralgia in the elderly: Particularities in prevention, diagnosis, and treatment]. Gac Med Mex. 2017; 153(1):92-101. View

3.
Sorel O, Messaoudi I . Varicella Virus-Host Interactions During Latency and Reactivation: Lessons From Simian Varicella Virus. Front Microbiol. 2019; 9:3170. PMC: 6308120. DOI: 10.3389/fmicb.2018.03170. View

4.
Nagel M, Gilden D . Neurological complications of varicella zoster virus reactivation. Curr Opin Neurol. 2014; 27(3):356-60. PMC: 4189810. DOI: 10.1097/WCO.0000000000000092. View

5.
Van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B . A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021; 17(6):1714-1732. PMC: 8115759. DOI: 10.1080/21645515.2020.1847582. View